April 17, 2018 | Israeli life sciences venture capital fund aMoon Partners, co-founded by Dr. Yair Schindel and Marius Nacht, also the billionaire co-founder of cybersecurity giant CheckPoint Software Technologies, announced that it raised $200 million, with a goal for a total of $500 million, to invest in mid- to late-stage companies in the health and medical technologies field. The funds were raised from private investors. “The opportunity is vast,” Schindel said, according to Bloomberg. “There are about 1,500 life-sciences startups in Israel, of all types, and about 10 percent of them are mid- to late-stage opportunities. That’s a huge pipeline that we’re following very closely.” The average investment will be between $10 million and $40 million, he said, adding that most of the investments will be in Israel with possible opportunities in the US, the UK, and Switzerland. The first aMoon health fund was set up in 2017, with Nacht putting up $200 million. The fund invested in 16 startups.
Facebook comments